PPARG and diabetes mellitus: Thiazolidines, a class of pharmaceutical agents primarily used for the treatment of type 2 diabetes mellitus, exert their effects through the agonistic activity of peroxisome proliferator-activated receptor gamma (PPARγ) (Gamo et al., 2014).